Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 6;38(1):69-75.
doi: 10.1080/08998280.2024.2426439. eCollection 2025.

Herpes zoster ophthalmicus temporally after COVID-19 vaccination: a systematic review of uncontrolled case reports and case series

Affiliations

Herpes zoster ophthalmicus temporally after COVID-19 vaccination: a systematic review of uncontrolled case reports and case series

Jawad Muayad et al. Proc (Bayl Univ Med Cent). .

Abstract

Purpose: Herpes zoster ophthalmicus (HZO) following COVID-19 vaccination has been reported previously but the clinical characteristics, onset, treatment, and outcomes of these cases have not been previously systematically reviewed.

Methods: A systematic review, guided by PRISMA guidelines, surveyed PubMed and Embase databases from April 2021 to June 2023 for case reports and series detailing HZO following COVID-19 vaccination. Studies excluded were abstracts, reviews, and clinical trials. A subsequent descriptive analysis was performed, focusing on patient demographics, clinical characteristics, and outcomes.

Results: Sixteen publications involving 27 participants who developed HZO post-COVID-19 vaccination met the inclusion criteria. The onset of HZO averaged 13 days (SD 12) postvaccination, predominantly after the first dose (n = 20/27 HZO cases, 74%). Most patients (70%) had preexisting medical conditions. Antiherpetic antiviral therapy was utilized in all cases, with the majority achieving resolution of cutaneous and ocular symptoms. Long-term sequelae included postherpetic neuralgia in 7.4% of patients.

Conclusion: Cases of HZO following COVID-19 vaccination generally mirror the clinical trajectory of HZO in general. This review focused on case reports describing HZO occurring in an interval postvaccination; neither association nor causation can be addressed methodologically.

Keywords: COVID-19 vaccination; herpes zoster ophthalmicus; systematic review; varicella-zoster virus.

PubMed Disclaimer

Conflict of interest statement

Andrew G. Lee, MD, has served as a speaker for Amgen and Alexion; is on the Advisory Board for Viridian; and is a consultant for Stoke, AstraZeneca, and Bristol Myers Squib. All other authors report no conflicts of interest.

Figures

Figure 1.
Figure 1.
PRISMA flow diagram.

Similar articles

References

    1. Cohen EJ, Jeng BH.. Herpes zoster: a brief definitive review. Cornea. 2021;40(8):943–949. doi:10.1097/ICO.0000000000002754. - DOI - PMC - PubMed
    1. Patil A, Goldust M, Wollina U.. Herpes zoster: a review of clinical manifestations and management. Viruses. 2022;14(2):192. doi:10.3390/v14020192. - DOI - PMC - PubMed
    1. Singh RB, Parmar UPS, Ichhpujani P, Jeng BH, Jhanji V.. Herpetic eye disease after SARS-CoV-2 vaccination: a CDC-VAERS database analysis. Cornea. 2023;42(6):731–738. doi:10.1097/ICO.0000000000003246. - DOI - PubMed
    1. Moher D, Liberati A, Tetzlaff J, Altman DG.. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–269, W64. doi:10.7326/0003-4819-151-4-200908180-00135. - DOI - PubMed
    1. Murad MH, Sultan S, Haffar S, Bazerbachi F.. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23(2):60–63. doi:10.1136/bmjebm-2017-110853. - DOI - PMC - PubMed

LinkOut - more resources